Rivaroxaban for preventing venous thromboembolism in high-risk ambulatory patients with cancer: rationale and design of the Cassini trial. Rationale and design of the CASSINI trial - Khorana, A A; Vadhan-Raj, S; Kuderer, N M (Thromb Haemost, 2017)
, et al.